HK1159475A1 - Scf extract containing cardiac glycoside - Google Patents

Scf extract containing cardiac glycoside

Info

Publication number
HK1159475A1
HK1159475A1 HK11113646.8A HK11113646A HK1159475A1 HK 1159475 A1 HK1159475 A1 HK 1159475A1 HK 11113646 A HK11113646 A HK 11113646A HK 1159475 A1 HK1159475 A1 HK 1159475A1
Authority
HK
Hong Kong
Prior art keywords
extract containing
cardiac glycoside
scf extract
containing cardiac
scf
Prior art date
Application number
HK11113646.8A
Other languages
English (en)
Inventor
Crandell Addington
Feng Zhang
John J Koleng
Original Assignee
Phoenix Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phoenix Biotechnology Inc filed Critical Phoenix Biotechnology Inc
Publication of HK1159475A1 publication Critical patent/HK1159475A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
HK11113646.8A 2005-07-28 2011-12-19 Scf extract containing cardiac glycoside HK1159475A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/191,650 US7402325B2 (en) 2005-07-28 2005-07-28 Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander

Publications (1)

Publication Number Publication Date
HK1159475A1 true HK1159475A1 (en) 2012-08-03

Family

ID=37694622

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11113646.8A HK1159475A1 (en) 2005-07-28 2011-12-19 Scf extract containing cardiac glycoside

Country Status (15)

Country Link
US (3) US7402325B2 (ko)
EP (1) EP1909807B1 (ko)
JP (3) JP5081152B2 (ko)
KR (2) KR101515681B1 (ko)
CN (2) CN101400358B (ko)
AR (1) AR055358A1 (ko)
AU (1) AU2006275891B2 (ko)
BR (1) BRPI0614484A2 (ko)
CA (1) CA2609808C (ko)
ES (1) ES2390843T3 (ko)
GT (1) GT200600338A (ko)
HK (1) HK1159475A1 (ko)
MX (1) MX2008001261A (ko)
RU (1) RU2398591C2 (ko)
WO (1) WO2007016176A2 (ko)

Families Citing this family (141)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7402325B2 (en) 2005-07-28 2008-07-22 Phoenix Biotechnology, Inc. Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander
JP5484735B2 (ja) * 2006-01-31 2014-05-07 ザ、ユニバーシティー、オブ、トレド Ｎａ／Ｋ−ＡＴＰアーゼリガンド
KR101556797B1 (ko) * 2006-08-18 2015-10-01 에보니크 룀 게엠베하 양호한 수용해도를 가지는 활성 성분을 위한 활성 성분 전달이 제어되는 제약 조성물
CA2667251C (en) 2006-10-31 2018-05-29 University Of Toledo Na+/k+-atpase-specific peptide inhibitors/activators of src and src family kinases
US8486465B1 (en) 2007-07-09 2013-07-16 Douglas CRAWFORD Therapeutic nerium oleander extract compositions and methods of using
MX2010005081A (es) * 2007-11-13 2010-06-23 Phoenix Biotechnology Inc Metodo para determinar la probabilidad de una respuesta terapeutica en la quimioterapia para el cancer con un glicosido cardiaco.
EP2320729B1 (en) 2008-08-07 2015-04-22 Centrose, Llc Glycoside compounds and pharmaceutical compositions thereof
CA2739029C (en) * 2008-10-14 2018-07-10 Nerium Biotechnology, Inc. Process for extracting cardiac glycosides from plants and compositions comprising cardiac glycosides from nerium oleander
TR200900312A2 (tr) * 2009-01-15 2010-08-23 Levent Baş Ahmet Nerium oleander'in tip II diyabet, obezite, yüksek kolesterol ve trigliserid düzeyi ile seyreden hastalıklar ve kardiovasküler hastalıklarda kullanımı@
ES2555252T3 (es) 2009-09-16 2015-12-30 The University Of Toledo Ligandos de Na/K-ATPasa, antagonistas de ouabaína, ensayos y uso de los mismos
US10307450B2 (en) 2010-01-11 2019-06-04 Phoenix Biotechnology, Inc. Method of treating neurological conditions with extract of Nerium species or Thevetia species
US9011937B2 (en) 2010-11-22 2015-04-21 Phoenix Biotechnology, Inc. Method of treating neurological conditions with extract of Nerium species or Thevetia species
WO2011085307A1 (en) * 2010-01-11 2011-07-14 Phoenix Biotechnology, Inc. Method of treating neurological conditions with cardiac glycosides
US10383886B2 (en) 2010-01-11 2019-08-20 Phoenix Biotechnology, Inc. Method of treating neurological conditions with oleandrin
WO2011088210A1 (en) 2010-01-13 2011-07-21 The University Of Toledo Materials and methods related to sodium/potassium adenosine triphosphatase and src
US9066974B1 (en) 2010-11-13 2015-06-30 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
US8541382B2 (en) 2010-11-13 2013-09-24 Sirbal Ltd. Cardiac glycoside analogs in combination with emodin for cancer therapy
US9095606B1 (en) 2010-11-13 2015-08-04 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
KR20170049623A (ko) * 2010-11-22 2017-05-10 피닉스 바이오테크놀러지 인코포레이티드. 네리움 종 또는 테베티아 종의 추출물로 신경학적 병태를 치료하는 방법
MY153035A (en) * 2011-03-15 2014-12-31 Univ Sains Malaysia A plant-based cancer chemopreventive agent
WO2012176215A1 (en) * 2011-06-20 2012-12-27 Pundaleekappa Shinhasan Manohar A plant based antiviral composition for the treatment of hiv and hiv related acquired immuno deficiency syndrome
JP6255346B2 (ja) 2011-10-20 2017-12-27 ネリウム バイオテクノロジー，インコーポレーテッド 癌治療のための治療用組合せ
FR2985187B1 (fr) * 2012-01-04 2015-11-20 Lvmh Rech Extrait de graines de kniphofia uvaria, composition cosmetique ou dermatologique en contenant, et ses utilisations.
US9561245B2 (en) 2012-09-06 2017-02-07 The Board Of Regents Of The University Of Texas System Combination treatments for melanoma
US9125841B2 (en) * 2013-02-26 2015-09-08 Johnson & Johnson Consumer Inc. Oral care compositions
US9572828B2 (en) * 2013-07-18 2017-02-21 The Board Of Regents Of The University Of Texas System Treatment for melanoma
JP6526065B2 (ja) 2014-02-28 2019-06-05 ニンバス ラクシュミ， インコーポレイテッド Ｔｙｋ２阻害剤およびその使用
CN117088931A (zh) 2014-08-12 2023-11-21 莫纳什大学 定向淋巴的前药
TWI788655B (zh) 2015-02-27 2023-01-01 美商林伯士拉克許米公司 酪胺酸蛋白質激酶2(tyk2)抑制劑及其用途
US10063316B2 (en) * 2016-04-30 2018-08-28 Nanoprecision Products, Inc. Wall plate having a built-in modem for performing electrical-to-optical conversion, optical-to-electrical conversion and protocol-to-protocol conversion
WO2017004134A1 (en) 2015-06-29 2017-01-05 Nimbus Iris, Inc. Irak inhibitors and uses thereof
JP6802263B2 (ja) 2015-09-02 2020-12-16 ニンバス ラクシュミ， インコーポレイテッド Ｔｙｋ２阻害剤およびその使用
CN118063537A (zh) 2015-09-08 2024-05-24 莫纳什大学 定向淋巴的前药
WO2017044720A1 (en) 2015-09-11 2017-03-16 Navitor Pharmaceuticals, Inc. Rapamycin analogs and uses thereof
LT3364958T (lt) 2015-10-23 2023-06-12 Navitor Pharmaceuticals, Inc. Sestrin-gator2 sąveikos moduliatoriai ir jų panaudojimas
EP3389664A4 (en) 2015-12-14 2020-01-08 Raze Therapeutics Inc. MTHFD2 CAFFEIN INHIBITORS AND USES THEREOF
ES2965264T3 (es) 2016-03-09 2024-04-11 Raze Therapeutics Inc Inhibidores de la 3-fosfoglicerato deshidrogenasa y sus usos
WO2017156179A1 (en) 2016-03-09 2017-09-14 Raze Therapeutics, Inc. 3-phosphoglycerate dehydrogenase inhibitors and uses thereof
WO2017177230A1 (en) 2016-04-08 2017-10-12 X4 Pharmaceuticals, Inc. Methods for treating cancer
WO2017223243A1 (en) 2016-06-21 2017-12-28 X4 Pharmaceuticals, Inc. Cxcr4 inhibitors and uses thereof
CA3027495A1 (en) 2016-06-21 2017-12-28 X4 Pharmaceuticals, Inc. Cxcr4 inhibitors and uses thereof
CN109562106B (zh) 2016-06-21 2023-03-21 X4 制药有限公司 Cxcr4抑制剂及其用途
IT201600080802A1 (it) * 2016-08-01 2018-02-01 Gionas S R L Medicamento per il trattamento e/o la prevenzione dell’endometriosi.
US10729735B1 (en) 2016-09-14 2020-08-04 Phoenix Biotechnology, Inc. Method and compostitions for treating coronavirus infection
EP3512524B1 (en) 2016-09-14 2021-04-07 Phoenix Biotechnology, Inc. Method and compositions for treating viral infection
US10702567B2 (en) 2016-09-14 2020-07-07 Phoenix Biotechnology, Inc. Method and compositions for treating viral infection
US10596186B2 (en) 2016-09-14 2020-03-24 Phoenix Biotechnology, Inc. Method and compositions for treating viral infections
JP7082130B2 (ja) 2016-10-14 2022-06-07 ニンバス ラクシュミ， インコーポレイテッド Ｔｙｋ２阻害剤およびその使用
AU2017345736B2 (en) 2016-10-21 2022-04-07 Takeda Pharmaceutical Company Limited TYK2 inhibitors and uses thereof
WO2018089499A1 (en) 2016-11-08 2018-05-17 Navitor Pharmaceuticals, Inc. PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF
EP3548005A4 (en) 2016-11-29 2020-06-17 Puretech Health LLC EXOSOMES FOR THE ADMINISTRATION OF THERAPEUTIC AGENTS
WO2018106636A1 (en) 2016-12-05 2018-06-14 Raze Therapeutics, Inc. Shmt inhibitors and uses thereof
CN110603261A (zh) 2016-12-23 2019-12-20 拜斯科阿迪有限公司 具有新型键结构的肽衍生物
EP3565638B8 (en) 2017-01-06 2024-04-10 BicycleRD Limited Bicycle conjugate for treating cancer
CN106924720B (zh) * 2017-02-21 2020-08-28 中山大学 罗布麻酸性多糖穿膜肽口服胰岛素纳米复合物的制备方法
IL269036B2 (en) 2017-03-08 2023-03-01 Nimbus Lakshmi Inc tyk2 inhibitors, uses and methods for their production
EP3375784A1 (en) 2017-03-14 2018-09-19 Artax Biopharma Inc. Aza-dihydro-acridone derivatives
EP3375778A1 (en) 2017-03-14 2018-09-19 Artax Biopharma Inc. Aryl-piperidine derivatives
WO2018191146A1 (en) 2017-04-10 2018-10-18 Navitor Pharmaceuticals, Inc. Heteroaryl rheb inhibitors and uses thereof
AU2018258355B2 (en) 2017-04-26 2024-05-30 Navitor Pharmaceuticals, Inc. Modulators of sestrin-gator2 interaction and uses thereof
WO2018197893A1 (en) 2017-04-27 2018-11-01 Bicycletx Limited Bicyclic peptide ligands and uses thereof
WO2019002842A1 (en) 2017-06-26 2019-01-03 Bicyclerd Limited BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF
EP3424493A1 (en) 2017-07-07 2019-01-09 SolMic Research GmbH Stable cannabinoid compositions
CN111194317A (zh) 2017-07-28 2020-05-22 林伯士拉克许米公司 Tyk2抑制剂与其用途
US20200291096A1 (en) 2017-08-14 2020-09-17 Bicyclerd Limited Bicyclic peptide ligand sting conjugates and uses thereof
US20200283482A1 (en) 2017-08-14 2020-09-10 Bicyclerd Limited Bicyclic peptide ligand prr-a conjugates and uses thereof
US11883497B2 (en) 2017-08-29 2024-01-30 Puretech Lyt, Inc. Lymphatic system-directing lipid prodrugs
EP3675838A4 (en) 2017-08-29 2021-04-21 PureTech LYT, Inc. LIPID PRODUCTS DIRECTED TO THE LYMPHATIC SYSTEM
KR102295179B1 (ko) * 2017-09-14 2021-08-30 피닉스 바이오테크놀러지 인코포레이티드. 바이러스 감염 치료를 위한 방법 및 조성물
US11331291B2 (en) 2017-09-14 2022-05-17 Phoenix Biotechnology, Inc. Method of and improved composition for treating triterpene-responsive conditions, diseases or disorders
RU2758376C2 (ru) 2017-09-14 2021-10-28 Феникс Байотекнолоджи, Инк. Способ и улучшенная нейропротекторная композиция для лечения неврологических патологических состояний
WO2019060693A1 (en) 2017-09-22 2019-03-28 Kymera Therapeutics, Inc. CRBN LIGANDS AND USES THEREOF
IL273432B (en) 2017-09-22 2022-09-01 Kymera Therapeutics Inc Protein compounds and their uses
GB201721265D0 (en) 2017-12-19 2018-01-31 Bicyclerd Ltd Bicyclic peptide ligands specific for EphA2
TWI825046B (zh) 2017-12-19 2023-12-11 英商拜西可泰克斯有限公司 Epha2特用之雙環胜肽配位基
EP3727362A4 (en) 2017-12-19 2021-10-06 PureTech LYT, Inc. MYCOPHENOLIC ACID LIPID MEDICINAL PRODUCTS AND THEIR USES
US11608345B1 (en) 2017-12-19 2023-03-21 Puretech Lyt, Inc. Lipid prodrugs of rapamycin and its analogs and uses thereof
US11304954B2 (en) 2017-12-19 2022-04-19 Puretech Lyt, Inc. Lipid prodrugs of mycophenolic acid and uses thereof
WO2019133531A1 (en) 2017-12-26 2019-07-04 Kymera Therapeutics, Inc. Irak degraders and uses thereof
EP3737675A4 (en) 2018-01-12 2022-01-05 Kymera Therapeutics, Inc. CRBN LIGANDS AND THEIR USES
EP3737666A4 (en) 2018-01-12 2022-01-05 Kymera Therapeutics, Inc. PROTEIN DEGRADANTS AND USES THEREOF
SG11202006832YA (en) 2018-01-29 2020-08-28 Merck Patent Gmbh Gcn2 inhibitors and uses thereof
IL301089A (en) 2018-01-29 2023-05-01 Vertex Pharma GCN2 inhibitors and their uses
US10696663B2 (en) 2018-02-27 2020-06-30 Artax Biopharma Inc. Chromene derivatives as inhibitors of TCR-NCK interaction
IL301501B1 (en) 2018-04-24 2024-06-01 Vertex Pharma Antiproliferative compounds and their uses
AR114828A1 (es) 2018-04-24 2020-10-21 Vertex Pharma Compuestos de pteridinona y sus usos
CN117843659A (zh) 2018-06-15 2024-04-09 詹森药业有限公司 雷帕霉素类似物和其用途
US11180531B2 (en) 2018-06-22 2021-11-23 Bicycletx Limited Bicyclic peptide ligands specific for Nectin-4
GB201810316D0 (en) 2018-06-22 2018-08-08 Bicyclerd Ltd Peptide ligands for binding to EphA2
EP3817748A4 (en) 2018-07-06 2022-08-24 Kymera Therapeutics, Inc. TRICYCLIC CRBN LIGANDS AND USES THEREOF
US10548889B1 (en) 2018-08-31 2020-02-04 X4 Pharmaceuticals, Inc. Compositions of CXCR4 inhibitors and methods of preparation and use
US20220089587A1 (en) 2018-09-07 2022-03-24 PIC Therapeutics, Inc. Eif4e inhibitors and uses thereof
CN113271940A (zh) 2018-10-15 2021-08-17 林伯士拉克许米公司 Tyk2抑制剂和其用途
EP3870597A1 (en) 2018-10-23 2021-09-01 BicycleTx Limited Bicyclic peptide ligands and uses thereof
US11345654B2 (en) 2018-10-24 2022-05-31 Navitor Pharmaceuticals, Inc. Polymorphic compounds and uses thereof
JP2022516401A (ja) 2018-11-30 2022-02-28 カイメラ セラピューティクス， インコーポレイテッド Ｉｒａｋ分解剤およびそれらの使用
JP2022509260A (ja) 2018-11-30 2022-01-20 ニンバス ラクシュミ， インコーポレイテッド Ｔｙｋ２阻害剤およびその使用
EP3670659A1 (en) 2018-12-20 2020-06-24 Abivax Biomarkers, and uses in treatment of viral infections, inflammations, or cancer
JP2022518505A (ja) 2019-01-23 2022-03-15 ニンバス ラクシュミ， インコーポレイテッド Ｔｙｋ２阻害剤およびその使用
WO2020165600A1 (en) 2019-02-14 2020-08-20 Bicycletx Limited Bicyclic peptide ligand sting conjugates and uses thereof
CN109832597B (zh) * 2019-03-25 2022-04-12 郑州雪麦龙食品香料有限公司 一种提高花椒麻素回收率的提取工艺
JP2022528887A (ja) 2019-04-02 2022-06-16 バイスクルテクス・リミテッド バイシクルトキシンコンジュゲートおよびその使用
SG11202110829YA (en) 2019-04-05 2021-10-28 Kymera Therapeutics Inc Stat degraders and uses thereof
AU2020282759A1 (en) 2019-05-31 2021-12-23 Ikena Oncology, Inc. TEAD inhibitors and uses thereof
TW202118770A (zh) 2019-07-30 2021-05-16 英商拜西可泰克斯有限公司 異質雙環肽複合物
JP2022548594A (ja) 2019-09-11 2022-11-21 ビンシア・バイオサイエンシーズ・インコーポレイテッド Ｕｓｐ３０阻害剤及びその使用
KR20220105631A (ko) 2019-09-13 2022-07-27 님버스 새턴 인코포레이티드 Hpk1 길항제 및 이의 용도
BR112022008287A2 (pt) 2019-11-01 2022-07-26 Navitor Pharm Inc Métodos de tratamento usando um modulador de mtorc1
TW202134234A (zh) 2019-12-05 2021-09-16 美商奈維特製藥公司 雷帕黴素類似物及其用途
BR112022011651A2 (pt) 2019-12-17 2022-08-23 Kymera Therapeutics Inc Degradadores de irak e usos dos mesmos
US11591332B2 (en) 2019-12-17 2023-02-28 Kymera Therapeutics, Inc. IRAK degraders and uses thereof
JP2023509394A (ja) 2019-12-23 2023-03-08 カイメラ セラピューティクス， インコーポレイテッド Ｓｍａｒｃａ分解剤およびそれらの使用
EP4100017A4 (en) 2020-02-05 2024-04-10 PureTech LYT, Inc. LIPID PRODRUGS OF NEUROSTEROIDS
AR121506A1 (es) 2020-03-03 2022-06-08 Pic Therapeutics Inc Inhibidores del eif4e y sus usos
JP2023518423A (ja) 2020-03-19 2023-05-01 カイメラ セラピューティクス， インコーポレイテッド Ｍｄｍ２分解剤およびそれらの使用
US11806359B2 (en) 2020-03-31 2023-11-07 Phoenix Biotechnology, Inc. Method and compositions for treating Coronavirus infection
JP7153083B2 (ja) 2020-03-31 2022-10-13 フェニックス・バイオテクノロジー・インコーポレイテッド コロナウイルス感染を治療するための方法および組成物
EP4295854A3 (en) 2020-03-31 2024-04-03 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection
TW202210483A (zh) 2020-06-03 2022-03-16 美商凱麥拉醫療公司 Irak降解劑之結晶型
WO2022038158A1 (en) 2020-08-17 2022-02-24 Bicycletx Limited Bicycle conjugates specific for nectin-4 and uses thereof
CN111875662B (zh) * 2020-08-19 2022-08-16 中国人民解放军空军军医大学 一种美花铁线莲茎化学提取物的提取方法和应用
EP4255895A1 (en) 2020-12-02 2023-10-11 Ikena Oncology, Inc. Tead inhibitors and uses thereof
WO2022120353A1 (en) 2020-12-02 2022-06-09 Ikena Oncology, Inc. Tead inhibitors and uses thereof
CN112704074B (zh) * 2021-01-05 2022-11-25 广东省田园农业生物科技有限公司 一种天然植物内源成分的提取方法
BR112023015590A2 (pt) 2021-02-02 2023-10-17 Liminal Biosciences Ltd Antagonistas de gpr84 e usos dos mesmos
BR112023015584A2 (pt) 2021-02-02 2023-10-24 Liminal Biosciences Ltd Antagonistas de gpr84 e usos dos mesmos
CN117295737A (zh) 2021-03-05 2023-12-26 林伯士萨顿公司 Hpk1拮抗剂和其用途
IL307673A (en) 2021-04-16 2023-12-01 Ikena Oncology Inc MEK inhibitors and their use
CN113321696B (zh) * 2021-06-30 2022-05-31 广西师范大学 一种强心苷的制备方法及其在制备抗肿瘤药物中的应用
CN118019739A (zh) 2021-08-25 2024-05-10 皮克医疗公司 Eif4e抑制剂及其用途
TW202315621A (zh) 2021-08-25 2023-04-16 美商皮克醫療公司 Ｅｉｆ４ｅ抑制劑及其用途
CN114181051B (zh) * 2021-12-14 2024-05-07 广州杨森药业有限公司 一种桃柁酚的制备方法及其应用
WO2023114984A1 (en) 2021-12-17 2023-06-22 Ikena Oncology, Inc. Tead inhibitors and uses thereof
WO2023173053A1 (en) 2022-03-10 2023-09-14 Ikena Oncology, Inc. Mek inhibitors and uses thereof
WO2023173057A1 (en) 2022-03-10 2023-09-14 Ikena Oncology, Inc. Mek inhibitors and uses thereof
WO2023211889A1 (en) 2022-04-25 2023-11-02 Ikena Oncology, Inc. Polymorphic compounds and uses thereof
TW202404581A (zh) 2022-05-25 2024-02-01 美商醫肯納腫瘤學公司 Ｍｅｋ抑制劑及其用途
WO2024028365A1 (en) 2022-08-02 2024-02-08 Liminal Biosciences Limited Substituted pyridone gpr84 antagonists and uses thereof
WO2024028364A1 (en) 2022-08-02 2024-02-08 Liminal Biosciences Limited Aryl-triazolyl and related gpr84 antagonists and uses thereof
WO2024028363A1 (en) 2022-08-02 2024-02-08 Liminal Biosciences Limited Heteroaryl carboxamide and related gpr84 antagonists and uses thereof
WO2024112894A1 (en) 2022-11-22 2024-05-30 PIC Therapeutics, Inc. Eif4e inhibitors and uses thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1394196A (en) * 1971-10-03 1975-05-14 Hisamitsu Pharmaceutical Co Process for isolating oleandrin from nerium odorum
BE896610A (fr) * 1982-05-06 1983-08-16 Hop Developments Ltd Extraction d'une matiere vegetale en utilisant de l'anhydride carbonique
JPS62496A (ja) 1985-06-27 1987-01-06 Mitsui Petrochem Ind Ltd 配糖体の抽出方法
FI872106A (fi) * 1986-05-13 1987-11-14 Huseyin Ziya Ozel Extrakt av nerium-arter, foerfarande foer framstaellning av dem och deras anvaendning.
JPS6333341A (ja) * 1986-07-28 1988-02-13 Seitetsu Kagaku Co Ltd 配糖体の処理方法
US4816259A (en) * 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
US5236132A (en) * 1992-01-03 1993-08-17 Vortec, Inc. Gradient-force comminuter/dehydrator apparatus and method
US5598979A (en) * 1995-04-20 1997-02-04 Vortec, Inc. Closed loop gradient force comminuting and dehydrating system
DE19535031A1 (de) * 1995-09-21 1997-03-27 Goldschmidt Ag Th Verfahren zur Auftrennung von Alkylglycosiden
CA2191923C (en) 1996-12-03 2000-10-24 Ji-Won Yoon Portulaca oleracea and tumor cell growth
AU6056999A (en) * 1998-09-24 2000-04-10 Ozelle Pharmaceuticals, Inc. Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6517015B2 (en) * 2000-03-21 2003-02-11 Frank F. Rowley, Jr. Two-stage comminuting and dehydrating system and method
US6715705B2 (en) * 2001-03-16 2004-04-06 Frank F. Rowley, Jr. Two-stage comminuting and dehydrating system and method
US20040082521A1 (en) 2002-03-29 2004-04-29 Azaya Therapeutics Inc. Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
AU2003287526A1 (en) 2002-11-06 2004-06-03 Protein-stabilized liposomal formulations of pharmaceutical agents
US6737552B1 (en) * 2003-03-27 2004-05-18 Lance B. Crombie Method for extracting lutein from green plant materials
WO2004087121A2 (en) 2003-03-28 2004-10-14 Azaya Therapeutics, Inc. Water soluble formulations of digitalis glycosides for treating cell-proliferative and other diseases
US20050112059A1 (en) * 2003-10-06 2005-05-26 Phoenix Biotechnology, Inc. Enhancement of radiotherapy by an exogenous cardiac glycoside
GB0411703D0 (en) * 2004-05-25 2004-06-30 Phytopharm Plc Selective separation or extraction of steroidal glycosides
DE102004061669A1 (de) 2004-12-22 2006-07-13 Man Roland Druckmaschinen Ag Druckmaschinenwalze sowie Druckmaschinenzylinder
US7402325B2 (en) 2005-07-28 2008-07-22 Phoenix Biotechnology, Inc. Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander

Also Published As

Publication number Publication date
RU2398591C2 (ru) 2010-09-10
EP1909807B1 (en) 2012-05-16
GT200600338A (es) 2007-02-12
US8187644B2 (en) 2012-05-29
KR101186089B1 (ko) 2012-09-27
KR101515681B1 (ko) 2015-05-07
WO2007016176A3 (en) 2008-11-20
US20120219620A1 (en) 2012-08-30
CA2609808A1 (en) 2007-02-08
AU2006275891B2 (en) 2011-06-30
US8394434B2 (en) 2013-03-12
ES2390843T3 (es) 2012-11-19
MX2008001261A (es) 2008-03-25
KR20110092360A (ko) 2011-08-17
RU2008107585A (ru) 2009-09-10
JP6058920B2 (ja) 2017-01-11
AR055358A1 (es) 2007-08-22
WO2007016176A2 (en) 2007-02-08
US20080200401A1 (en) 2008-08-21
JP2009502942A (ja) 2009-01-29
CN101400358B (zh) 2013-06-05
BRPI0614484A2 (pt) 2011-03-29
CA2609808C (en) 2016-08-30
JP6113205B2 (ja) 2017-04-12
KR20080030613A (ko) 2008-04-04
CN102172363B (zh) 2013-04-24
CN101400358A (zh) 2009-04-01
US7402325B2 (en) 2008-07-22
JP2015096546A (ja) 2015-05-21
AU2006275891A1 (en) 2007-02-08
JP5081152B2 (ja) 2012-11-21
US20070026092A1 (en) 2007-02-01
CN102172363A (zh) 2011-09-07
EP1909807A2 (en) 2008-04-16
JP2012197298A (ja) 2012-10-18

Similar Documents

Publication Publication Date Title
HK1159475A1 (en) Scf extract containing cardiac glycoside
ZA200708438B (en) External preparation for skin
HK1122991A1 (en) External preparation for skin
EP1872294A4 (en) VIRTUAL LAND
GB0505941D0 (en) Human-to-mobile interfaces
GB0525954D0 (en) External Emulation Hardware
EP2027849A4 (en) TOPICAL SKIN PREPARATION
EP2073891A4 (en) PACEMAKER
IL190307A0 (en) Bullet-proof structure
EP2223929A4 (en) GAMBOGIN LYCOSIDE DERIVATIVES AND ANALOGUES, THEIR PREPARATION AND THEIR APPLICATION
EP1949895A4 (en) IONTOPHORESIS-PREPARATION
GB2458228B (en) External preparation for skin
EP1961415A4 (en) ADHESIVE PREPARATION
EP1938808A4 (en) PREPARATION FOR TOPICAL APPLICATION
EP1915126A4 (en) NEW SKIN IMPROVING COMPOSITION
EP1845900A4 (en) Heart valve inserter
TWM285923U (en) Improved self-adhesive brassiere
TWI369394B (en) As-indacene derivatives
HK1129310A1 (en) Isosorbide preparation
PL1948305T3 (pl) Konstrukcja łopatki do defibrylacji
GB0525964D0 (en) Interjecting bag
AU304204S (en) Cabinet
TWM292722U (en) Retaining structure for attached card
HK1091088A2 (en) Brassiere
GB0504220D0 (en) Helicopter